Cargando…
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer
Background: Efforts to prevent recurrence in gastric cancer (GC) patients are limited by current incomplete understanding of the pathological mechanisms. The present study aimed to identify novel tumour metastasis-associated genes and investigate potential value of these genes in clinical diagnosis...
Autores principales: | Chen, Qi-Yue, Huang, Xiao-Bo, Zhao, Ya-Jun, Wang, Hua-Gen, Wang, Jia-Bin, Liu, Li-Chao, Wang, Ling-Qian, Zhong, Qing, Xie, Jian-Wei, Lin, Jian-Xian, Lu, Jun, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Zheng, Chao-Hui, Li, Ping, Huang, Chang-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825587/ https://www.ncbi.nlm.nih.gov/pubmed/35198079 http://dx.doi.org/10.7150/thno.66814 |
Ejemplares similares
-
Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015) -
Identification of mammalian transcription factors that bind to inaccessible chromatin
por: Pop, Romana T, et al.
Publicado: (2023) -
Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
por: Wang, Xue-Jiao, et al.
Publicado: (2014) -
Protective effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on endotoxin-induced acute lung injury in rats
por: Liu, D, et al.
Publicado: (2005) -
ΔNp63 is a pioneer factor that binds inaccessible chromatin and elicits chromatin remodeling
por: Yu, Xinyang, et al.
Publicado: (2021)